TRPV1 protein controls the nerves that release noradrenaline and affect core body temperature. This opens the doors for the development of new strategies to treat the effects of stress on the body. The study was published in The FASEB Journal.
"The findings of our study give a greater insight into how body temperature is controlled, vital to improving the control of core body temperature in situations such as anesthesia, drug overdose and diseases in which core body temperature is pathologically abnormal," said Julie Keeble, Ph.D., a researcher involved in the work from the Institute of Pharmaceutical Science at King's College in London, England.
Keeble and colleagues conducted experiments using normal mice and mice bred to have no TRPV1 protein in their bodies. Drugs that blocked TRPV1 were administered to normal mice and their body temperature increased. The same drugs had no effect in the genetically altered mice. Normal mice that were given drugs that blocked the effects of noradrenaline before giving the TRPV1 blocker demonstrated a much smaller increase in body temperature. The genetically altered mice surprisingly showed a normal body temperature under normal conditions, which led to further study. The researchers found that the "fight or flight" response in the mice was reduced, including after administration of amphetamine, which is known to increase levels of noradrenaline.
Subscribe to PharmaTutor News Alerts by Email >>
